Advertisement
Law and Government

Parliamentary Panel Urges Doubling Ayushman Bharat Cover to ₹10 Lakh on July 10

July 10, 2026
08:31 PM
3 min read

Key Points

Parliamentary committee recommends raising Ayushman Bharat cover from ₹5 lakh to ₹10 lakh annually.

Current limit inadequate for liver transplants, cardiac surgeries, and immunotherapy treatments.

Scheme covers 43 crore cardholders across 35 states with 11.46 crore authorised admissions.

Implementation requires health ministry approval and state government coordination.

Be the first to rate this article

India’s parliamentary standing committee on health has recommended raising the Ayushman Bharat insurance cap to ₹10 lakh from ₹5 lakh per family annually. The current limit leaves beneficiaries vulnerable to massive out-of-pocket costs for procedures like liver transplants, cardiac surgeries, and immunotherapy that now exceed the threshold. The scheme currently covers 43 crore cardholders across 35 states and Union Territories.

Advertisement

Why the current ₹5 lakh limit is no longer enough

Medical costs have surged beyond the scheme’s existing ceiling. Liver transplants, complex cardiac surgeries, and immunotherapy treatments now cost far more than ₹5 lakh. The committee observed that advances in medical treatment have pushed high-end procedures well beyond coverage, forcing many beneficiaries to pay substantial amounts themselves despite being enrolled in the government scheme.

How the committee proposes to fund the increase

The panel recommended a differential treatment cost model for high-cost procedures, supported through pooled financing, negotiated pricing with hospitals and manufacturers, and co-funding with states. This targeted approach would ensure expensive life-saving procedures remain accessible while maintaining fiscal sustainability. The committee also wants hospitals to approve cashless treatments within six hours, with penalties for delays.

Current scheme reach and impact

Ayushman Bharat-Pradhan Mantri Jan Arogya Yojana (PM-JAY) provides cashless health cover for secondary and tertiary care across 35 states and Union Territories. As of January 31, 2026, the scheme had authorised 11.46 crore hospital admissions worth ₹1.69 lakh crore. More than 43 crore Ayushman cards have been issued, making it India’s largest government-funded health insurance programme. The committee’s recommendation aims to strengthen coverage for the poorest families.

What happens next

The recommendation now goes to the health ministry for consideration. Implementation would require budget allocation and coordination with state governments. The panel also pushed for universal Ayushman Card distribution, especially in remote areas where uptake remains low. No timeline has been announced for a decision.

Advertisement

Final Thoughts

The ₹10 lakh proposal would double coverage for 43 crore cardholders, protecting vulnerable families from catastrophic medical debt. Implementation depends on ministry approval and state coordination, with no firm timeline yet.

FAQs

Why does Ayushman Bharat need to raise its coverage limit?

Modern treatments like liver transplants and cardiac surgeries now cost more than ₹5 lakh, leaving patients with massive out-of-pocket bills despite scheme coverage.

How many people currently use Ayushman Bharat?

Over 43 crore Ayushman cards have been issued across 35 states and Union Territories, with 11.46 crore hospital admissions authorised as of January 2026.

Will the ₹10 lakh increase happen automatically?

No. The parliamentary committee’s recommendation must be reviewed by the health ministry before any implementation decision is made.

What other changes did the committee recommend?

The panel proposed six-hour cashless treatment approvals with penalties for delays, pooled financing for high-cost procedures, and universal Ayushman Card distribution in remote areas.

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.

About Author

Author

Huzaifa Zahoor

Co Founder

Huzaifa Zahoor is the engineer who built Meyka. He has spent years writing Python, training AI models, and building data pipelines specifically for financial markets. His technical articles have reached over 30,000 readers on Medium, so he knows how to make complex things easy to follow. If this article touches on how the tools work, he is the person who actually built them.

What brings you to Meyka?

Pick what interests you most and we will get you started.

I'm here to read news

Find more articles like this one

I'm here to research stocks

Ask Meyka Analyst about any stock

I'm here to track my Portfolio

Get daily updates and alerts (coming March 2026)